GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.
about
Complex role of autophagy in regulation of hepatic lipid and lipoprotein metabolismBrain Control of Plasma Cholesterol Involves Polysialic Acid Molecules in the Hypothalamus.Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosisCooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.Intranasal administration of Exendin-4 antagonizes Aβ31-35-induced disruption of circadian rhythm and impairment of learning and memory.The bone-preserving effects of exendin-4 in ovariectomized rats.Alleviating VLDL overproduction is an important mechanism for Laminaria japonica polysaccharide to inhibit atherosclerosis in LDLr-/- mice with diet-induced insulin resistance.Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study.
P2860
Q26747101-6EF02B41-B3FB-455A-8DFC-C1FE75852AC0Q33630983-CBA1B4CC-9552-41EE-B452-BCAFF02AF267Q38923365-B21538DA-22B2-404A-A4DE-060A0583B51EQ40990999-629BCBA4-D45B-4778-86BC-B316532710B5Q47343137-E5A34800-FF03-4D63-9896-C3E635A5F81AQ48127350-A0E94200-8414-403E-BEC9-4315B0684D97Q48875327-66F96EA9-A22C-48BD-BF4E-C903325F444CQ51012841-5F6BB394-BAB6-4FC3-A270-9128CA5325A8Q51084242-33E7D81C-E309-4145-9D56-BF07BC2FBEAAQ52721601-663B2A11-BC66-48A1-8A19-A2890871B4EBQ53964243-165A5BE4-1C80-44BB-800B-5BD798320E6F
P2860
GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@en
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@nl
type
label
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@en
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@nl
prefLabel
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@en
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@nl
P2093
P2860
P1433
P1476
GLP-1 receptor agonism amelior ...... genesis in insulin resistance.
@en
P2093
Carmelle Cuizon
Celine Bourdon
Christopher L Baker
Hassan Masoudpour
Jennifer Taher
Khosrow Adeli
Mark Naples
Rianna Zhang
Sarah Farr
Zdenka Pausova
P2860
P304
P356
10.1016/J.MOLMET.2014.09.005
P577
2014-09-28T00:00:00Z